Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alistair Fielder

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Pediatrics|May 3, 2008
Lower stress responses after Newborn Individualized Developmental Care and Assessment Program care during eye screening examinations for retinopathy of prematurity: a randomized studyAgneta Kleberg, Inga Warren, Elisabeth Norman, et al.
Lancet (London, England)|September 17, 2019
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trialAndreas Stahl, Domenico Lepore, Alistair Fielder, et al.
JAMA Ophthalmology|December 14, 2018
Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical TrialsLois E H Smith, Ann Hellström, Andreas Stahl, et al.
JAMA Network Open|April 30, 2024
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE nextAndreas Stahl, Hidehiko Nakanishi, Domenico Lepore, et al.
American Journal of Human Genetics|April 23, 2005
Heterozygous mutations of OTX2 cause severe ocular malformationsNicola K Ragge, Alison G Brown, Charlotte M Poloschek, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Pediatrics|May 3, 2008
Lower stress responses after Newborn Individualized Developmental Care and Assessment Program care during eye screening examinations for retinopathy of prematurity: a randomized studyAgneta Kleberg, Inga Warren, Elisabeth Norman, et al.
Lancet (London, England)|September 17, 2019
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trialAndreas Stahl, Domenico Lepore, Alistair Fielder, et al.
JAMA Ophthalmology|December 14, 2018
Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical TrialsLois E H Smith, Ann Hellström, Andreas Stahl, et al.
JAMA Network Open|April 30, 2024
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE nextAndreas Stahl, Hidehiko Nakanishi, Domenico Lepore, et al.
American Journal of Human Genetics|April 23, 2005
Heterozygous mutations of OTX2 cause severe ocular malformationsNicola K Ragge, Alison G Brown, Charlotte M Poloschek, et al.
Pageof 2